Endurant Capital Management LP Viridian Therapeutics, Inc.\De Transaction History

Endurant Capital Management LP

  • $0
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$9.55 - $19.0 $794,722 - $1.58 Million
-83,217 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$16.79 - $20.88 $264,727 - $329,214
15,767 Added 23.38%
83,217 $1.54 Million
Q4 2021

Feb 14, 2022
BUY
$15.65 - $21.5 $1.06 Million - $1.45 Million
67,450 New
67,450 $1.33 Million

Others Institutions Holding VRDN

# of Institutions
179
Shares Held
76.8M
Call Options Held
581K
Put Options Held
439K
View Full List

About Viridian Therapeutics, Inc.\DE

VRDN Quotes by TradingView
  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $839M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Endurant Capital Management LP Portfolio

Follow Endurant Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Endurant Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email